The US has approved Hemgenix - a one-time intravenous treatment for hemophilia B, a disorder in which people do not produce a protein needed to create blood clots and control bleeding.
I love the part that says:
Like most medicines in the US, most of the cost of the new treatment will be paid by insurers — not patients — including private plans and government programs.
(Excuse me, but just where do you think THAT money comes from?)
OK, my complaint is I don't care how much "research" went into it. That's what your company does for a living..research and producing meds. NO medicine should cost 3.5 million for a one time treatment. Bad enough I have a drug that is close to $700 a month and hubs and I are both on it. When I'm in the "donut hole", which is now, I have to pay out of pocket 25% of that cost. It's Trelegy which is little puffs of powdered medication in a disc. Greed...this is pure greed plain and simple.